Both in Pharmaceuticals
Syndax Pharmaceuticals vs ANI Pharmaceuticals
Over the past year SNDX returned +17.2% and ANIP returned −21.0%; their daily moves had a correlation of 0.07.
SNDX +17.2% ANIP −21.0%Growth of $1, one year, split-adjusted
| Metric | SNDX | ANIP |
|---|---|---|
| Price | $18.24 | $72.62 |
| Market cap | $1.63B | $1.67B |
| Today | +2.10% | −2.95% |
| 1 month | −6.7% | −0.3% |
| 6 months | −18.9% | −1.5% |
| Year to date | −13.2% | −8.0% |
| 1 year | +16.3% | −22.0% |
| Revenue growth (YoY) | +91.8% | +25.9% |
| Gross margin | 95.6% | 62.4% |
| Net margin | −67.8% | 8.6% |
| P/E (TTM) | — | 16.7× |
| Price / sales | 6.5× | 1.7× |
| Net cash | -$41.0M | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | 44.1% | 30.1% |
| Short % of float | 24.5% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).